Consolidated statement of income

In € millions, for the year ended December 31

Note

 

2019*

 

2020

 

 

 

 

 

 

Continuing operations

 

 

 

 

 

Revenue

5

9,276

 

8,530

 

Cost of sales

6

(5,314)

 

(4,745)

 

Gross profit

 

 

3,962

 

3,785

Selling expenses

6

(2,217)

 

(1,916)

 

General and administrative expenses

6

(637)

 

(663)

 

Research and development expenses

6

(262)

 

(238)

 

Other results

6

(5)

 

(5)

 

 

 

 

(3,121)

 

(2,822)

Operating income

 

 

841

 

963

Financing income and expenses

8

(76)

 

(69)

 

Results from associates and joint ventures

14

20

 

25

 

Profit before tax

 

 

785

 

919

Income tax

9

 

(230)

 

(241)

Profit for the period from continuing operations

 

 

555

 

678

 

 

 

 

 

 

Discontinued operations

 

 

 

 

 

Profit/(loss) for the period from discontinued operations

2

 

22

 

(7)

Profit for the period

 

 

577

 

671

 

 

 

 

 

 

Attributable to

 

 

 

 

 

Shareholders of the company

 

 

539

 

630

Non-controlling interests

 

 

38

 

41

Profit for the period

 

 

577

 

671

 

 

 

 

 

 

Earnings per share, in €

 

 

 

 

 

Continuing operations

 

 

 

 

 

Basic

10

 

2.43

 

3.33

Diluted

10

 

2.42

 

3.32

Discontinued operations

 

 

 

 

 

Basic

10

 

0.10

 

(0.04)

Diluted

10

 

0.10

 

(0.04)

Total operations

 

 

 

 

 

Basic

10

 

2.53

 

3.29

Diluted

10

 

2.52

 

3.28

*

Costs by nature 2019 have been reclassified to align to our 2020 cost structure and allocations. This resulted in reclassifications between cost lines in our statement of income, which did not impact total operating income.